Olema Pharmaceuticals, Inc. (OLMA) has 53 open-market insider trades by 16 insiders since 2020. Over the last six months insiders net sold $291K. The most active filer is Cyrus Harmon, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| G. Walmsley Graham | Dir | — | 5 | $75.5M | 2024-12-17 |
| Paradigm Biocapital Advisors LP | 10% Owner | — | 1 | $71.6M | 2024-08-01 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | Dir10% Owner | — | 2 | $31.2M | 2023-09-14 |
| Biotechnology VALUE FUND II L.P. | Dir10% Owner | — | 1 | $21.6M | 2020-11-19 |
| Ian T. Clark | Dir | — | 1 | $15.7M | 2025-12-19 |
| Biotechnology VALUE FUND L P | Dir10% Owner | — | 1 | $13.9M | 2021-11-30 |
| Naseem Zojwalla | — | — | 3 | $13.2M | 2025-12-23 |
| Cormorant Global Healthcare Master Fund, LP | Dir10% Owner | — | 1 | $8.1M | 2020-11-23 |
| David C. Myles | — | — | 5 | $7.1M | 2026-01-14 |
| Shane William Charles Kovacs | — | — | 3 | $4.0M | 2026-01-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Cyrus Harmon | Director | Sell | $291K | 2026-07-23 |
| Shawnte Mitchell | CLO | Sell | $952K | 2026-03-03 |
| Cyrus Harmon | Director | Sell | $269K | 2026-01-20 |
| Cyrus Harmon | Director | Sell | $102K | 2026-01-14 |
| Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | Sell | $3.0M | 2026-01-13 |
| David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sell | $3.1M |
Companies that share insiders with OLMA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-01-12 |
| Cyrus Harmon | Director | Sell | $164K | 2025-12-22 |
| Ian T. Clark | Director | Sell | $15.7M | 2025-12-19 |
| Naseem Zojwalla | — | Sell | $12.3M | 2025-12-19 |
| David C. Myles | — | Sell | $3.1M | 2025-12-19 |
| Cyrus Harmon | Director | Sell | $285K | 2025-09-16 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | $1.7M | 2025-01-08 |
| G. Walmsley Graham | Director | Buy | $4.7M | 2024-12-17 |
| G. Walmsley Graham | Director | Sell | $9.5M | 2024-12-17 |
| G. Walmsley Graham | Director | Buy | $9.5M | 2024-12-13 |